dc.contributor.author | Stoycheva, K | |
dc.contributor.author | Cristea, V | |
dc.contributor.author | Ködmön, C | |
dc.contributor.author | Rosales-Klintz, S | |
dc.contributor.author | Zenner, D | |
dc.contributor.author | Vasiliu, A | |
dc.contributor.author | van der Werf, M | |
dc.contributor.author | Lange, C | |
dc.date.accessioned | 2024-07-29T10:51:20Z | |
dc.date.available | 2024-07-29T10:51:20Z | |
dc.date.issued | 2024-03-21 | |
dc.identifier.citation | Citation style for this article: Stoycheva Krista, Cristea Veronica, Ködmön Csaba, Rosales-Klintz Senia, Zenner Dominik, Vasiliu Anca, van der Werf Marieke, Lange Christoph. Tuberculosis in people of Ukrainian origin in the European Union and the European Economic Area, 2019 to 2022. Euro Surveill. 2024;29(12):pii=2400094. https://doi.org/10.2807/1560-7917.ES.2024.29.12.2400094 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/98448 | |
dc.description.abstract | Approximately five million Ukrainians were displaced to the EU/EEA following the Russian invasion of Ukraine. While tuberculosis (TB) notification rates per 100,000 Ukrainians in the EU/EEA remained stable, the number of notified TB cases in Ukrainians increased almost fourfold (mean 2019-2021: 201; 2022: 780). In 2022, 71% cases were notified in three countries, and almost 20% of drug-resistant TB cases were of Ukrainian origin. Targeted healthcare services for Ukrainians are vital for early diagnosis and treatment, and preventing transmission. | en_US |
dc.language | eng | |
dc.publisher | European Centre for Disease Prevention and Control | en_US |
dc.relation.ispartof | Euro Surveill | |
dc.rights | This work is licensed under a Creative Commons Attribution 4.0 International License. | |
dc.subject | COVID-19 | en_US |
dc.subject | DR | en_US |
dc.subject | EU/EEA | en_US |
dc.subject | Europe | en_US |
dc.subject | RR/MDR | en_US |
dc.subject | Russia | en_US |
dc.subject | TB | en_US |
dc.subject | Ukraine | en_US |
dc.subject | XDR | en_US |
dc.subject | conflict | en_US |
dc.subject | drug resistance | en_US |
dc.subject | migration | en_US |
dc.subject | pre-XDR | en_US |
dc.subject | tuberculosis | en_US |
dc.subject | war | en_US |
dc.subject | Humans | en_US |
dc.subject | European Union | en_US |
dc.subject | Population Surveillance | en_US |
dc.subject | Tuberculosis | en_US |
dc.subject | Eastern European People | en_US |
dc.subject | Tuberculosis, Multidrug-Resistant | en_US |
dc.title | Tuberculosis in people of Ukrainian origin in the European Union and the European Economic Area, 2019 to 2022. | en_US |
dc.type | Article | en_US |
dc.rights.holder | © This article is copyright of the authors or their affiliated institutions, 2024. | |
dc.identifier.doi | 10.2807/1560-7917.ES.2024.29.12.2400094 | |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/38516786 | en_US |
pubs.issue | 12 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 29 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
rioxxterms.funder.project | b215eee3-195d-4c4f-a85d-169a4331c138 | en_US |